Melinda E Sanders

发表

Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy.

Thomas E Yankeelov, Lori R Arlinghaus, Vandana G Abramson, 2013, Translational oncology.

A Multistage Genetic Association Study Identifies Breast Cancer Risk Loci at 10q25 and 16q24

Joan P Breyer, Kevin M. Bradley, Amy Trentham-Dietz, 2012, Cancer Epidemiology, Biomarkers & Prevention.

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

Gordon B Mills, Carlos L Arteaga, Justin M Balko, 2014, Breast Cancer Research.

A multistage association study identifies a breast cancer genetic locus at NCOA7.

Joan P Breyer, Kevin M. Bradley, Amy Trentham-Dietz, 2011, Cancer research.

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Yu Shyr, Jonathan M Irish, Anna E Vilgelm, 2016, Nature Communications.

Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections.

Roy A Jensen, Richard M Caprioli, Pierre Chaurand, 2004, The American journal of pathology.

Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer.

Alex J Walsh, Melissa C Skala, Alex J. Walsh, 2014, Cancer research.

A Novel Histology-directed Strategy for MALDI-MS Tissue Profiling That Improves Throughput and Cellular Specificity in Human Breast Cancer*

Richard M Caprioli, Carlos L Arteaga, R. Caprioli, 2006, Molecular & Cellular Proteomics.

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Yan Guo, Yu Shyr, Nadia Solovieff, 2019, Nature Communications.

Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.

Richard M Caprioli, Stacey R Oppenheimer, R. Caprioli, 2010, Journal of proteome research.